{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:13:54Z","timestamp":1777619634457,"version":"3.51.4"},"reference-count":62,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.toxlet.2010.12.017","type":"journal-article","created":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T09:22:31Z","timestamp":1293873751000},"page":"130-136","source":"Crossref","is-referenced-by-count":22,"title":["The iron-chelating drug triapine causes pronounced mitochondrial thiol redox stress"],"prefix":"10.1016","volume":"201","author":[{"given":"Judith M.","family":"Myers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William E.","family":"Antholine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Zielonka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles R.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2010.12.017_bib0005","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jsgi.2005.11.004","article-title":"Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone) induces apoptosis in ovarian cancer cells","volume":"13","author":"Alvero","year":"2006","journal-title":"J. Soc. Gynecol. Investig."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0010","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.bbagen.2009.01.014","article-title":"Focus on mammalian thioredoxin reductases \u2013 important selenoproteins with versatile functions","volume":"1790","author":"Arn\u00e9r","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.toxlet.2010.12.017_bib0015","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.1046\/j.1432-1327.2000.01701.x","article-title":"Physiological functions of thioredoxin and thioredoxin reductase","volume":"267","author":"Arn\u00e9r","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0020","doi-asserted-by":"crossref","first-page":"8233","DOI":"10.1074\/jbc.M809338200","article-title":"Molecular mechanisms of thioredoxin and glutaredoxin as hydrogen donors for mammalian S phase ribonucleotide reductase","volume":"284","author":"Avval","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0025","first-page":"327","article-title":"Direct determination of tissue aminothtiol, disulfide, and thioether levels using HPLC-ED with a novel stable boron-doped diamond working electrode","volume":"vol. 594","author":"Baily","year":"2009"},{"key":"10.1016\/j.toxlet.2010.12.017_bib0030","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.taap.2004.09.008","article-title":"Molecular mechanisms of reduced glutathione transport: role of the MRP\/CFTR\/ABCC and OATP\/SLC21A families of membrane proteins","volume":"204","author":"Ballatori","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0035","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1042\/BJ20050337","article-title":"Proteomic detection of hydrogen peroxide-sensitive thiol proteins in Jurkat cells","volume":"389","author":"Baty","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0040","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/0006-2952(87)90087-6","article-title":"Formation and reduction of glutathione-protein mixed disulfides during oxidative stress. A study with isolated hepatocytes and menadione (2-methyl-1,4-naphthoquinone)","volume":"36","author":"Bellomo","year":"1987","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0045","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/jcc.20404","article-title":"Determination of the \u0394pKa between the active site cysteines of thioredoxin and DsbA","volume":"27","author":"Carvalho","year":"2006","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0050","doi-asserted-by":"crossref","first-page":"41975","DOI":"10.1074\/jbc.M407707200","article-title":"Peroxiredoxin III, a mitochondrion-specific peroxidase, regulates apoptotic signaling by mitochondria","volume":"279","author":"Chang","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0055","first-page":"402","article-title":"Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311","volume":"9","author":"Chaston","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0060","doi-asserted-by":"crossref","first-page":"6596","DOI":"10.1016\/j.febslet.2006.11.007","article-title":"Mitochondrial thioredoxin in regulation of oxidant-induced cell death","volume":"580","author":"Chen","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0065","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.taap.2006.05.006","article-title":"Protection against oxidant-induced apoptosis by mitochondrial thioredoxin in SH-SY5Y neuroblastoma cells","volume":"216","author":"Chen","year":"2006","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0070","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.freeradbiomed.2007.11.017","article-title":"Oxidation of mitochondrial peroxiredoxin 3 during the initiation of receptor-mediated apoptosis","volume":"44","author":"Cox","year":"2008","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0075","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.clim.2006.06.010","article-title":"The transferrin receptor. Part I. Biology and targeting with cytotoxic antibodies for the treatment of cancer","volume":"121","author":"Daniels","year":"2006","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0080","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.freeradbiomed.2009.09.016","article-title":"High levels of thioredoxin reductase 1 modulate drug-specific cytotoxic efficacy","volume":"47","author":"Eriksson","year":"2009","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0085","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0006-2952(99)00419-0","article-title":"Triapine (3-aminopyridine-2-carboxaldehyde-thiosemicarbazone): a potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity","volume":"59","author":"Finch","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0065-2571(98)00017-X","article-title":"Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone; 3-AP): an inhibitor of ribonucleotide reductase with antineoplastic activity","volume":"39","author":"Finch","year":"1999","journal-title":"Adv. Enzyme Regul."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0095","doi-asserted-by":"crossref","first-page":"20096","DOI":"10.1074\/jbc.273.32.20096","article-title":"Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds","volume":"273","author":"Gromer","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0100","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/mnfr.200700527","article-title":"Cancer chemoprevention and mitochondria: targeting apoptosis in transformed cells via the disruption of mitochondrial bioenergetics\/redox state","volume":"53","author":"Hail","year":"2009","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0105","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1042\/BJ20041829","article-title":"Compartmental oxidation of thiol-disulphide redox couples during epidermal growth factor signalling","volume":"386","author":"Halvey","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0110","doi-asserted-by":"crossref","first-page":"14337","DOI":"10.1074\/jbc.M611019200","article-title":"Glutathione export during apoptosis requires functional multidrug resistance-associated proteins","volume":"282","author":"Hammond","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0115","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1146\/annurev.pharmtox.46.120604.141122","article-title":"Nuclear and mitochondrial compartmentation of oxidative stress and redox signaling","volume":"46","author":"Hansen","year":"2006","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0120","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.freeradbiomed.2005.09.023","article-title":"Differential oxidation of thioredoxin-1, thioredoxin-2, and glutathione by metal ions","volume":"40","author":"Hansen","year":"2006","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0125","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S1476-5586(03)80034-9","article-title":"The transferrin receptor: a potential molecular imaging marker for human cancer","volume":"5","author":"Hogemann-Savellano","year":"2003","journal-title":"Neoplasia"},{"key":"10.1016\/j.toxlet.2010.12.017_bib0130","doi-asserted-by":"crossref","first-page":"4600","DOI":"10.1016\/S0021-9258(17)40204-3","article-title":"Bovine thioredoxin system. Purification of thioredoxin reductase from calf liver and thymus and studies of its function in disulfide reduction","volume":"252","author":"Holmgren","year":"1977","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0135","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1021\/tx700039c","article-title":"Future of toxicology \u2013 iron chelators and differing modes of action and toxicity: the changing face of iron chelation therapy","volume":"20","author":"Kalinowski","year":"2007","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0140","article-title":"Population pharmacokinetics of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (Triapine\u00ae) in cancer patients","author":"Kolesar","year":"2010","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0145","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1158\/1078-0432.CCR-09-2469","article-title":"Phase I trial of pelvic radiation, weekly cisplatin, and 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) for locally advanced cervical cancer","volume":"16","author":"Kunos","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0150","first-page":"3894","article-title":"Ionizing radiation-induced, mitochondria-dependent generation of reactive oxygen\/nitrogen","volume":"61","author":"Leach","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0155","doi-asserted-by":"crossref","first-page":"9986","DOI":"10.1074\/jbc.M800426200","article-title":"Oxidative modification of peroxiredoxin is associated with drug-induced apoptotic signaling in experimental models of Parkinson disease","volume":"283","author":"Lee","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0160","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1158\/1535-7163.1319.3.10","article-title":"Cells resistant to HTI-286 do not overexpress P-glycoprotein but have reduced drug accumulation and a point mutation in alpha-tubulin","volume":"3","author":"Loganzo","year":"2004","journal-title":"Mol. Cancer Ther."},{"issue":"Suppl. 1","key":"10.1016\/j.toxlet.2010.12.017_bib0165","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/sj.cdd.4401625","article-title":"The thioredoxin system in retroviral infection and apoptosis","volume":"12","author":"Masutani","year":"2005","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0170","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tox.2008.12.013","article-title":"The effects of acrolein on peroxiredoxins, thioredoxins, and thioredoxin reductase in human bronchial epithelial cells","volume":"257","author":"Myers","year":"2009","journal-title":"Toxicology"},{"key":"10.1016\/j.toxlet.2010.12.017_bib0175","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.tox.2008.01.017","article-title":"Hexavalent chromium causes the oxidation of thioredoxin in human bronchial epithelial cells","volume":"246","author":"Myers","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.toxlet.2010.12.017_bib0180","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.freeradbiomed.2009.08.015","article-title":"The effects of hexavalent chromium on thioredoxin reductase and peroxiredoxins in human bronchial epithelial cells","volume":"47","author":"Myers","year":"2009","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0185","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1128\/MCB.23.3.916-922.2003","article-title":"The absence of mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly, and early embryonic lethality in homozygous mice","volume":"23","author":"Nonn","year":"2003","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0190","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0891-5849(01)00724-9","article-title":"Reactive oxygen species, antioxidants, and the mammalian thioredoxin system","volume":"31","author":"Nordberg","year":"2001","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0195","doi-asserted-by":"crossref","first-page":"11885","DOI":"10.1074\/jbc.M700339200","article-title":"The high reactivity of peroxiredoxin 2 with H2O2 is not reflected in its reaction with other oxidants and thiol reagents","volume":"282","author":"Peskin","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0200","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev.biophys.30.1.421","article-title":"Properties and biological activities of thioredoxins","volume":"30","author":"Powis","year":"2001","journal-title":"Annu. Rev. Biophys. Biomol. Struct."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0205","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0891-5849(00)00313-0","article-title":"The role of the redox protein thioredoxin in cell growth and cancer","volume":"29","author":"Powis","year":"2000","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0210","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0169-409X(01)00127-2","article-title":"Mitochondrial contributions to cancer cell physiology: potential for drug development","volume":"49","author":"Preston","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0215","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/mnfr.200800044","article-title":"Mitochondria as targets for cancer therapy","volume":"53","author":"Ralph","year":"2009","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0220","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0006-2952(97)00210-4","article-title":"Overexpression of the multidrug resistance genes mdr1, mdr3, and mrp in L1210 leukemia cells resistant to inhibitors of ribonucleotide reductase","volume":"54","author":"Rappa","year":"1997","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0225","doi-asserted-by":"crossref","first-page":"6510","DOI":"10.1021\/jm0606342","article-title":"Dipyridyl thiosemicarbazone chelators with potent and selective antitumor activity form iron complexes with redox activity","volume":"49","author":"Richardson","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0230","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0891-5849(01)00480-4","article-title":"Redox environment of the cell as viewed through the redox state of the glutathione disulfide\/glutathione couple","volume":"30","author":"Schafer","year":"2001","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0235","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/j.1432-1033.1994.tb18821.x","article-title":"S-thiolation of human endothelial cell glyceraldehyde-3-phosphate dehydrogenase after hydrogen peroxide treatment","volume":"221","author":"Schuppe-Koistinen","year":"1994","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0240","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1158\/1535-7163.MCT-05-0384","article-title":"A ferrous\u2013triapine complex mediates formation of reactive oxygen species that inactivate human ribonucleotide reductase","volume":"5","author":"Shao","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0245","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.1073\/pnas.0931245100","article-title":"Delivery of bioactive molecules to mitochondria in vivo","volume":"100","author":"Smith","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0250","doi-asserted-by":"crossref","first-page":"8269","DOI":"10.1158\/0008-5472.CAN-08-2010","article-title":"The thioredoxin system mediates redox-induced cell death in human colon cancer cells: implications for the mechanism of action of anticancer agents","volume":"68","author":"Sun","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0255","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.tox.2007.10.004","article-title":"Acrolein oxidizes the cytosolic and mitochondrial thioredoxins in human endothelial cells","volume":"243","author":"Szadkowski","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.toxlet.2010.12.017_bib0260","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/emboj\/21.7.1695","article-title":"Thioredoxin-2 (TRX-2) is an essential gene regulating mitochondria-dependent apoptosis","volume":"21","author":"Tanaka","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0265","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1432-1033.1994.00447.x","article-title":"Nitric oxide regulation of glyceraldehyde-3-phosphate dehydrogenase activity in Dictyostelium discoideum cells and lysates","volume":"224","author":"Tao","year":"1994","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0270","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.semcancer.2006.09.004","article-title":"On the potential of thioredoxin reductase inhibitors for cancer therapy","volume":"16","author":"Urig","year":"2006","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0275","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1200\/JCO.2004.07.158","article-title":"Phase I and pharmacokinetic study of the ribonucleotide reductase inhibitor, 3-aminopyridine-2-carboxaldehyde thiosemicarbazone, administered by 96-hour intravenous continuous infusion","volume":"22","author":"Wadler","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0280","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/path.1711480305","article-title":"Transferrin receptor expression in non-malignant and malignant human breast tissue","volume":"148","author":"Walker","year":"1986","journal-title":"J. Pathol."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0285","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.freeradbiomed.2006.05.029","article-title":"Molecular mechanism of glutathione-mediated protection from oxidized low-density lipoprotein-induced cell injury in human macrophages: role of glutathione reductase and glutaredoxin","volume":"41","author":"Wang","year":"2006","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0290","doi-asserted-by":"crossref","first-page":"33408","DOI":"10.1074\/jbc.M211107200","article-title":"Redox potential of human thioredoxin 1 and identification of a second dithiol\/disulfide motif","volume":"278","author":"Watson","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0295","doi-asserted-by":"crossref","first-page":"14901","DOI":"10.1073\/pnas.0604979103","article-title":"A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics","volume":"103","author":"Whitnall","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0300","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.freeradbiomed.2008.05.004","article-title":"Thiol chemistry and specificity in redox signaling","volume":"45","author":"Winterbourn","year":"2008","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0305","doi-asserted-by":"crossref","first-page":"6876","DOI":"10.1158\/1078-0432.CCR-06-1954","article-title":"Chelators at the cancer coalface: desferrioxamine to triapine and beyond","volume":"12","author":"Yu","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.toxlet.2010.12.017_bib0310","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1182\/blood-2004-03-0868","article-title":"Novel di-2-pyridyl-derived iron chelators with marked and selective antitumor activity: in vitro and in vivo assessment","volume":"104","author":"Yuan","year":"2004","journal-title":"Blood"}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427410018126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427410018126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T18:14:51Z","timestamp":1685902491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427410018126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0378427410018126"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2010.12.017","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}